SCHEMBL35794

SCHEMBL35794

CCCCc1ccc(C(C)(C)C)c(O)c1C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.43
CA2 P00918 1/20 0.39
ALOX5 P09917 2/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CTRC Q99895 1/20 0.37
ELANE P08246 1/20 0.35
CTSG P08311 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
PTGS2 P35354 1/20 0.35
HSPA5 P11021 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6897662 0.93 TYR (0.49) TYRALOX5CYP3A4MAPTMEN1
SCHEMBL3709017 0.93 TYR (0.49) TYRALOX5CYP3A4MAPTMEN1
SCHEMBL29170685 0.93 TYR (0.49) TYRALOX5CYP3A4MAPTMEN1
SCHEMBL1846556 0.93 TYR (0.49) TYRALOX5CYP3A4MAPTMEN1
SCHEMBL28307750 0.93 TYR (0.49) TYRALOX5CYP3A4MAPTMEN1
SCHEMBL30816147 0.93 TYR (0.49) TYRALOX5CYP3A4MAPTMEN1
SCHEMBL29766715 0.89 CA2 (0.42) TYRCA2TSHRKMT2ATDP1
SCHEMBL10904233 0.89 CA2 (0.42) TYRCA2TSHRKMT2ATDP1
SCHEMBL30697134 0.87 CA2 (0.46) TYRCA2CYP3A4MAPTMEN1
SCHEMBL10893525 0.87 CA2 (0.46) TYRCA2CYP3A4MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 EP claimed
US-20230390105-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC 2023-12-07 US claimed
EP-3787533-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY Femasys, Inc. (US) 2021-03-10 EP claimed
CN-110267687-A Composition and method including biodegradable cyanoacrylate 费玛塞斯公司 2019-09-20 CN claimed
WO-2018148453-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS, INC. (US) 2018-08-16 WO claimed
EP-2603552-B1 WOUND HEALING COMPOSITIONS BASED ON CYANOACRYLATES AND 5,5-DISUBSTITUTEDHYDANTOINS, INCLUDING PHENYTOIN ADHEZION BIOMEDICAL LLC (US) 2017-05-17 EP claimed
EP-2303343-B1 METHOD OF PREPARING ADHESIVE COMPOSITIONS FOR MEDICAL USE: SINGLE ADDITIVE AS BOTH THE THICKENING AGENT AND THE ACCELERATOR ADHEZION BIOMEDICAL LLC (US) 2016-01-13 EP claimed
US-3981813-A HYDROCARBON OILS STANDARD OIL COMPANY (INDIANA) (US) 1976-09-21 US claimed
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates FEMASYS INC. (US) 2026-04-21 US disclosed
US-12582546-B2 Methods and devices for controlled delivery FEMASYS INC. (US) 2026-03-24 US disclosed
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS FEMASYS INC (US) 2026-03-05 US disclosed
EP-4613213-A2 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS Femasys, Inc. (US) 2025-09-10 EP disclosed
EP-4385529-B1 DEVICES FOR CONTROLLED DELIVERY FEMASYS INC (US) 2025-07-16 EP disclosed
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 EP disclosed
US-20060006364-A1 Fluorene derivatives and polymers thereof CHISSO CORPORATION AND CHISSO PETROCHEMICAL CORPORATION 2006-01-12 US disclosed
EP-0604958-A2 Polymer finishing process UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1994-07-06 EP disclosed
US-5324798-A Removal of active polymer residue UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1994-06-28 US disclosed
EP-0489050-A1 ARYL ESTER AMIDE HALIDES OF PHOSPHONOUS ACID, ARYL ESTER AMIDES OF PHOSPHONOUS ACID, PROCESS FOR PREPARING THEM AND THEIR USE TO STABILIZE PLASTICS HOECHST AKTIENGESELLSCHAFT (DE) 1992-06-10 EP disclosed
US-4173664-A POLYXYLENES, STERICALLY HINDERED PHENOL UNION CARBIDE CORPORATION (US) 1979-11-06 US disclosed
US-4021385-A AMINES AND PHENOLS BASF WYANDOTTE CORPORATION (US) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS PGF, ACR, FGB TYR 66/4885CA2 1477/4885ALOX5 51/4885
US-12582546-B2 Methods and devices for controlled delivery PGF, GNRHR, LHCGR TYR 4782/4885CA2 3472/4885ALOX5 3633/4885
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates MKI67, ACR, PGF TYR 103/4885CA2 1260/4885ALOX5 172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.